Gaviscon Oral Suspension 500mg+267mg / 10ml

Product details
Therapeutic indications
Gaviscon Oral Suspension is used for the symptomatic treatment of occasional heartburn.

Dosage and method of use
Gaviscon Oral Suspension should be taken in the following doses and methods:

Adults and adolescents (12-18 years): 10-20 ml (second-fourth notch of the measuring cup or 2-4 measuring spoons or 1- 2 single-dose sachets) after meals and at bedtime. For oral administration. Shake the suspension before use.
Elderly: it is not necessary to change the doses for this age group.
Patients with renal insufficiency: the reduced ability to urinate the exogenous salt supplement provided by antacids can affect potentially severe electrolyte imbalances
Contraindications

Hypersensitivity to the active substances or to any of the excipients, including esters of hydroxybenzoates (parabens).
Severe renal insufficiency.
Special warnings
Do not use for prolonged treatments. In patients with very low gastric acid levels there is a possibility of lower efficacy. In adolescents (12-18 years) use only if clearly needed and under close medical supervision. In case of renal insufficiency, the medicine should be used with caution as the exogenous saline supplement provided by antacids can affect potentially severe electrolyte imbalances.

Each 500 mg + 267 mg tablet contains 123 mg (5.3 mmol) of sodium. Each 250 mg +133.5 mg tablet contains 61.5 mg (2.65 mmol) of sodium. Each 10 ml dose of suspension contains 141 mg (6.2 mmol) of sodium. This should be taken into consideration in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure and renal impairment. Each 500 mg + 267 mg tablet contains 160 mg (1.6 mmol) of calcium carbonate.

The suspension contains methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions. Delayed-type reactions (contact dermatitis) usually occur, rarely immediate reactions with urticaria and bronchospasm.

Pregnancy and breastfeeding
Use in case of real need and under strict medical supervision.

Expiry and retention
Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored. Do not store above 30 ° C. Store in the original packaging. Do not refrigerate.

Warning: do not use the medicine after the expiry date indicated on the package.

Composition
Gaviscon Oral Suspension contains:
Active ingredient: sodium alginate 500 mg, sodium bicarbonate 267 mg
Excipients: calcium carbonate; carbomers; methyl parahydroxybenzoate; propyl parahydroxybenzoate; sodium saccharin; fennel flavoring; sodium hydroxide; erythrosine; purified water.